2004 News
-
Press Release
-
IR News
-
Press Release
Santen to Purchase Own Shares on Market by ToSTNet-2[PDF:18 KB]
-
IR News
Santen to Purchase Own Shares on Market by ToSTNet-2[PDF:18 KB]
-
Press Release
Santen to Terminate Sales of Ophthalmic Surgical Instruments
-
IR News
Santen to Terminate Sales of Ophthalmic Surgical Instruments
-
Press Release
Santen Establishes New Retirement Benefit and Pension Program[PDF:35KB]
-
IR News
Santen Establishes New Retirement Benefit and Pension Program[PDF:35KB]
-
Press Release
Santen Announces Financial Results for the First Six Months ended September 30, 2004
-
IR News
Santen Announces Financial Results for the First Six Months ended September 30, 2004
-
Press Release
-
IR News
-
Press Release
-
IR News
-
Press Release
-
IR News
-
Press Release
Santen Launches Anti- rheumatic METOLATE® Tablets 2mg [PDF:16KB]
-
IR News
Santen Launches Anti- rheumatic METOLATE® Tablets 2mg [PDF:16KB]
-
Press Release
Agreement Concerning Glaucoma and Ocular Hypertension Treatment RESCULA® Eye Drops[PDF:22KB]
-
IR News
Agreement Concerning Glaucoma and Ocular Hypertension Treatment RESCULA® Eye Drops[PDF:22KB]
-
Press Release
Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)[PDF:15KB]
-
IR News
Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)[PDF?15KB]
-
Press Release
Santen Hosts the 92nd Annual General Meeting of Shareholders
-
IR News
Santen Hosts the 92nd Annual General Meeting of Shareholders
-
Press Release
Notice on the Allotment of Stock Options (Stock Acquisition Rights)[PDF:12KB]
-
IR News
Notice on the Allotment of Stock Options (Stock Acquisition Rights)[PDF:12KB]
-
Press Release
Santen to Issue Stock Acquisition Rights for the Purpose of Granting Stock Options [PDF:20KB]
-
IR News
Santen to Issue Stock Acquisition Rights for the Purpose of Granting Stock Options [PDF:20KB]
-
Press Release
Santen Announces Financial Results for the Year ended March 31, 2004 [PDF:57KB]
-
IR News
Santen Announces Financial Results for the Year ended March 31, 2004 [PDF:57KB]
-
Press Release
-
IR News
-
Press Release
-
IR News
-
Press Release
-
IR News
-
Press Release
Santen Receives FDA Approval of IQUIX, New Treatment for Sight-threatening Condition [PDF:19KB]
-
IR News
Santen Receives FDA Approval of IQUIX, New Treatment for Sight-threatening Condition [PDF:19KB]
-
Press Release
Santen Announces Financial Results for the Nine Months Ended December 31, 2003
-
IR News
Santen Announces Financial Results for the Nine Months Ended December 31, 2003